Dihydroartemisinin-Loaded Chitosan Nanoparticles Inhibit the Rifampicin-Resistant Mycobacterium tuberculosis by Disrupting the Cell Wall

Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) is a deadly infection, and increasing resistance worsens an already bad scenario. In this work, a new nanomedicine antibacterial agent, based on dihydroartemisinin (DHA) and chitosan (CS), has been successfully developed to overcome MTB’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Xiujuan, Cheng, Qi, He, Ping, Zhang, Yan, Jiang, Zhengfang, Zeng, Yali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500176/
https://www.ncbi.nlm.nih.gov/pubmed/34630358
http://dx.doi.org/10.3389/fmicb.2021.735166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500176/
https://www.ncbi.nlm.nih.gov/pubmed/34630358
http://dx.doi.org/10.3389/fmicb.2021.735166

Ejemplares similares